Characterization of etoricoxib, a novel, selective COX-2 inhibitor.
Dallob A, Hawkey CJ, Greenberg H, Wight N, De Schepper P, Waldman S, Wong P, DeTora L, Gertz B, Agrawal N, Wagner J, Gottesdiener K.
Dallob A, et al.
J Clin Pharmacol. 2003 Jun;43(6):573-85.
J Clin Pharmacol. 2003.
PMID: 12817520
Clinical Trial.